LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

AstraZeneca PLC ADR

Închisă

82.94 -0.01

Rezumat

Modificarea prețului

24h

Curent

Minim

82.94

Maxim

83.26

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+6.27 upside

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

AstraZeneca PLC ADR Grafic

Știri relevante

25 iul. 2024, 09:17 UTC

Câștiguri

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

25 iul. 2024, 06:48 UTC

Câștiguri

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

12 iul. 2024, 19:57 UTC

Principalele dinamici ale pieței

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

5 sept. 2024, 13:00 UTC

Top știri

China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ

29 iul. 2024, 10:30 UTC

Top știri

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

25 iul. 2024, 13:20 UTC

Câștiguri

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 iul. 2024, 09:21 UTC

Market Talk
Câștiguri

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

25 iul. 2024, 07:05 UTC

Market Talk
Câștiguri

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

25 iul. 2024, 06:06 UTC

Câștiguri

AstraZeneca Increased Interim Dividend by 7c to $1.00

25 iul. 2024, 06:04 UTC

Câștiguri

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

25 iul. 2024, 06:04 UTC

Câștiguri

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

25 iul. 2024, 06:04 UTC

Câștiguri

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 iul. 2024, 06:04 UTC

Câștiguri

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 iul. 2024, 06:03 UTC

Câștiguri

AstraZeneca Raises 2024 View

25 iul. 2024, 06:02 UTC

Câștiguri

AstraZeneca 2Q Revenue Consensus Was $12.7B

25 iul. 2024, 06:02 UTC

Câștiguri

AstraZeneca 2Q Core EPS Consensus Was $1.95

25 iul. 2024, 06:00 UTC

Câștiguri

AstraZeneca PLC 2Q Adj EPS $1.98

25 iul. 2024, 06:00 UTC

Câștiguri

AstraZeneca PLC 2Q Pretax Pft $2.4B

25 iul. 2024, 06:00 UTC

Câștiguri

AstraZeneca PLC 2Q Rev $12.94B

25 iul. 2024, 06:00 UTC

Câștiguri

AstraZeneca PLC 2Q Oper Pft $2.75B

25 iul. 2024, 06:00 UTC

Câștiguri

AstraZeneca PLC 2Q Net Pft $1.93B

25 iul. 2024, 06:00 UTC

Câștiguri

AstraZeneca PLC 2Q EPS $1.24

15 iul. 2024, 06:04 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 iul. 2024, 06:04 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 iul. 2024, 06:02 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15 iul. 2024, 06:02 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

15 iul. 2024, 06:01 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

15 iul. 2024, 06:00 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca Completes Acquisition of Amolyt Pharma

15 iul. 2024, 06:00 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca PLC Acquisition of Amolyt Pharma completed

15 iul. 2024, 06:00 UTC

Achiziții, Fuziuni, Preluări

AstraZeneca PLC Acquisition of Amolyt Pharma completed

Comparație

Modificare preț

AstraZeneca PLC ADR Așteptări

Obiectiv de preț

By TipRanks

6.27% sus

Prognoză pe 12 luni

Medie 88.26 USD  6.27%

Maxim 99 USD

Minim 74 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAstraZeneca PLC ADR - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

5

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

82.46 / 87.21Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

No Evidence